Two Sigma Securities LLC purchased a new stake in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 30,972 shares of the company’s stock, valued at approximately $1,376,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of America Corp DE lifted its position in Docusign by 23.3% during the first quarter. Bank of America Corp DE now owns 1,193,163 shares of the company’s stock valued at $56,568,000 after buying an additional 225,801 shares in the last quarter. Capital World Investors increased its position in shares of Docusign by 38.1% in the fourth quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock worth $397,801,000 after acquiring an additional 1,603,900 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in shares of Docusign by 247.5% in the 2nd quarter. Assenagon Asset Management S.A. now owns 349,038 shares of the company’s stock valued at $15,504,000 after acquiring an additional 248,597 shares during the period. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund purchased a new position in shares of Docusign in the 4th quarter valued at $6,897,000. Finally, Los Angeles Capital Management LLC acquired a new position in shares of Docusign during the 4th quarter valued at $1,750,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Docusign Stock Up 3.5%
Shares of NASDAQ DOCU opened at $66.27 on Tuesday. Docusign Inc. has a fifty-two week low of $40.16 and a fifty-two week high of $86.65. The business has a 50 day moving average price of $53.91 and a two-hundred day moving average price of $49.29. The firm has a market cap of $12.65 billion, a PE ratio of 43.03, a price-to-earnings-growth ratio of 1.86 and a beta of 0.87.
Insider Transactions at Docusign
In other Docusign news, CEO Allan C. Thygesen sold 26,250 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $46.02, for a total transaction of $1,208,025.00. Following the transaction, the chief executive officer directly owned 159,038 shares in the company, valued at $7,318,928.76. This represents a 14.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total transaction of $273,240.00. Following the transaction, the executive directly owned 89,972 shares of the company’s stock, valued at approximately $4,097,324.88. This represents a 6.25% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 90,965 shares of company stock valued at $4,341,688 over the last ninety days. 0.59% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the company. UBS Group set a $60.00 price target on Docusign in a report on Friday, June 5th. Citigroup reaffirmed a “market outperform” rating on shares of Docusign in a research report on Tuesday, August 18th. Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a research note on Friday, June 5th. Wedbush dropped their target price on Docusign from $60.00 to $58.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. Finally, BTIG Research reduced their price target on Docusign from $70.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Four research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $60.27.
View Our Latest Stock Analysis on Docusign
Docusign Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
- Five stocks we like better than Docusign
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
